Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5 | NEJM nejm.org Nawigacja wpisu Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections | NEJM – nejm.org Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial – The Lancet
